IL301055A - Sulfamoylurea derivatives including an alkyl-oxycycloalkyl unit and their uses - Google Patents
Sulfamoylurea derivatives including an alkyl-oxycycloalkyl unit and their usesInfo
- Publication number
- IL301055A IL301055A IL301055A IL30105523A IL301055A IL 301055 A IL301055 A IL 301055A IL 301055 A IL301055 A IL 301055A IL 30105523 A IL30105523 A IL 30105523A IL 301055 A IL301055 A IL 301055A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- disease
- disorder
- pct
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL301055A true IL301055A (en) | 2023-05-01 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL301055A IL301055A (en) | 2020-09-04 | 2021-09-03 | Sulfamoylurea derivatives including an alkyl-oxycycloalkyl unit and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP7865948B2 (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| AU (1) | AU2021336518B2 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| TW (1) | TWI916398B (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| HUE067378T2 (hu) | 2019-06-12 | 2024-10-28 | Nodthera Ltd | Szulfonilurea származékok és alkalmazásaik |
| JP7661248B2 (ja) | 2019-06-12 | 2025-04-14 | ノッドセラ リミテッド | スルホニル尿素誘導体及びその使用 |
| KR20260115622A (ko) * | 2023-11-17 | 2026-07-24 | 노드테라 리미티드 | 우레아 유도체의 제조 방법 |
| CN122555701A (zh) | 2023-11-17 | 2026-08-11 | 诺瑟拉有限公司 | 脲衍生物的形式和相关用途 |
| TW202545527A (zh) * | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| DK1270565T3 (da) | 1997-01-29 | 2004-10-04 | Pfizer | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| JP7412328B2 (ja) | 2017-07-24 | 2024-01-12 | ノバルティス アーゲー | Nlrp活性に関連する状態を治療するための化合物及び組成物 |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| SG11202101480XA (en) | 2018-08-15 | 2021-03-30 | Inflazome Ltd | Novel sulfonamideurea compounds |
-
2021
- 2021-09-03 JP JP2023514910A patent/JP7865948B2/ja active Active
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518B2/en active Active
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 TW TW110132880A patent/TWI916398B/zh active
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3191410A1 (en) | 2022-03-10 |
| TWI916398B (zh) | 2026-03-01 |
| BR112023003792A2 (pt) | 2023-03-28 |
| AU2021336518A1 (en) | 2023-03-23 |
| EP4208459A1 (en) | 2023-07-12 |
| AU2021336518B2 (en) | 2026-05-21 |
| MX2023002686A (es) | 2023-04-03 |
| AR123435A1 (es) | 2022-11-30 |
| JP2023540733A (ja) | 2023-09-26 |
| US20240043410A1 (en) | 2024-02-08 |
| KR20230061505A (ko) | 2023-05-08 |
| JP7865948B2 (ja) | 2026-05-26 |
| WO2022051582A1 (en) | 2022-03-10 |
| TW202229265A (zh) | 2022-08-01 |
| CN116783184A (zh) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12459925B2 (en) | Sulphonyl urea derivatives as NLRP3 inflammasome modulators | |
| US12247011B2 (en) | Selective inhibitors of NLRP3 inflammasome | |
| AU2021336518B2 (en) | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof | |
| US12624023B2 (en) | Sulfonylurea derivatives and uses thereof | |
| US12054461B2 (en) | Sulfonylurea derivatives and uses thereof | |
| US20220267300A1 (en) | Sulfonamide derivatives and uses thereof | |
| CA3247232A1 (en) | BICYCLIC DERIVATIVES OF PHTALAZIN-1(2H)-ONE AND ASSOCIATED USES | |
| RU2858266C2 (ru) | Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения | |
| US20250206745A1 (en) | Pyrrolopyridazine derivatives and related uses | |
| US20250115558A1 (en) | Pyridazine derivatives and related uses | |
| HK40039990A (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators | |
| HK40039990B (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators | |
| HK40031620A (en) | Selective inhibitors of nlrp3 inflammasome | |
| HK40031620B (en) | Selective inhibitors of nlrp3 inflammasome |